Thursday, February 19, 2015 10:32:58 AM
I don't agree that the publishing of the Regenesis comments re-sets any clocks. FDA has had, and no doubt has been carefully considering, all the comments since May 20th last year. The Regenesis comments are totally supportive of the reclassification efforts of FDA and endorse further simplification of related approval processes. I see the publication of the comments as simple housekeeping, or, in response to a request by Regenesis that it's comments be made public.
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM